期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 16, 期 21, 页码 5517-5522出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2006.08.040
关键词
prolyl hydroxylase inhibitors; HIF-1 alpha; hypoxia; ischemia; peripheral arterial disease (PAD); anemia; 8-hydroxyquinolinecarboxyamides
A new series of potent 8-hydroxyquinolines was designed based on the newly resolved X-ray crystal structure of EGLN-1. Both alkyl and aryl 8-hydroxyquinoline-7-carboxyamides were good HIF-1 alpha prolyl hydroxylase (EGLN) inhibitors. In subsequent VEGF induction assays, these exhibited potent VEGF activity. In addition, this class of compounds did show the ability to stabilize HIF-1 alpha. (c) 2006 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据